This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Patients With Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention | MicrobiomeTrials
← Back to trials NCT06821243
Patients With Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention Recruiting OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-07-24Est. Completion: 2026-07-24
Enrollment target: 40 participantsLocations IRCCS National Cancer Institute "Regina Elena", Rome, Rome, Italy Other microbiome trials you might be interested in HPV-positive Oropharyngeal Squamous Cell Carcinoma Oropharyngeal Squamous Cell Carcinoma
The purpose of this study is to assess risk for HPV driven oropharyngeal cancers by using HPV blood tests and clinical f…
Boston, United States Est. completion Jan 1, 2028
Merkel Cell Carcinoma Cutaneous Squamous Cell Carcinoma Basal Cell Carcinoma Triple Negative Breast Cancer Non-Small Cell Lung Cancer
Oropharynx Squamous Cell Carcinoma
The goal of this study is to learn if giving cemiplimab and vidutolimod together could be effective in treating advanced…
Birmingham, United States Completed Oct 31, 2024
Head and Neck Squamous Cell Carcinoma
This is a single-centre feasibility study designed to assess the safety, tolerability and engraftment of MET-4 bacterial…
Toronto, Canada Completed Sep 16, 2025